0001104659-23-098970.txt : 20230907 0001104659-23-098970.hdr.sgml : 20230907 20230907164646 ACCESSION NUMBER: 0001104659-23-098970 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230907 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SELECT MEDICAL HOLDINGS CORP CENTRAL INDEX KEY: 0001320414 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34465 FILM NUMBER: 231242808 BUSINESS ADDRESS: STREET 1: C/O SELECT MEDICAL CORP STREET 2: 4714 GETTYSBURG RD CITY: MECHANICSBURG STATE: PA ZIP: 17055 BUSINESS PHONE: 717-972-1100 MAIL ADDRESS: STREET 1: C/O SELECT MEDICAL CORP STREET 2: 4714 GETTYSBURG RD CITY: MECHANICSBURG STATE: PA ZIP: 17055 8-K 1 tm2325650d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

current report

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 7, 2023

SELECT MEDICAL HOLDINGS CORPORATION

(Exact Name of Registrant as Specified in Charter)

Delaware		001-34465		20-1764048
(State or Other Jurisdiction of Incorporation or Organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(Address of Principal Executive Offices) (Zip Code)

(717) 972-1100

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	SEM	New York Stock Exchange (NYSE)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether either registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if either registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Co-Presidents

On September 7, 2023, Select Medical Holdings Corporation, a Delaware corporation (“Select”), announced the appointments of John A. Saich, 55, and Thomas P. Mullin, 39, as Co-Presidents, effective October 1, 2023. David Chernow will no longer serve as President of Select as of October 1, 2023, but will continue to serve as Chief Executive Officer.

A 26-year veteran of Select, Mr. Saich most recently served as Executive Vice President and Chief Administrative Officer overseeing Select’s Outpatient Rehabilitation Division and Shared Services operations. During his tenure at Select, Mr. Saich has guided Select through successful growth and transition serving in a variety of senior operational and human resources leadership roles.

Since joining Select in 2008, Mr. Mullin has held operational leadership positions of increasing responsibility within the Critical Illness Recovery Hospital Division, including President. In 2018, his role expanded to the Inpatient Rehabilitation Hospital Division, serving as Chief Operating Officer. That post was followed by his appointment to Executive Vice President of Hospital Operations, including oversight of both divisions.

Mr. Saich’s annual base salary since January 1, 2022 has been $600,000 and he has received grants of 75,000 shares of restricted stock per year in each of 2022 and 2023, which were subject to three-year cliff vesting.

Mr. Mullin’s annual base salary since January 1, 2022 has been $561,000 and he has received grants of 75,000 shares of restricted stock per year in each of 2022 and 2023, which were subject to three-year cliff vesting.

There is no arrangement or understanding between Mr. Saich or Mr. Mullin and any other person pursuant to which Mr. Saich or Mr. Mullin is to be selected as an officer of Select that would require disclosure under Item 401(b) of Regulation S-K. Additionally, there is no family relationship between Mr. Saich or Mr. Mullin and any other person that would require disclosure under Item 401(d) of Regulation S-K.

Chief Financial Officer

On September 7, 2023, Select also announced the appointment of Michael F. Malatesta, 54, as the Chief Financial Officer of Select, effective October 1, 2023. Martin F. Jackson will no longer serve as Chief Financial Officer of Select as of October 1, 2023, but will continue to serve as Senior Executive Vice President of Strategic Finance and Operations.

Prior to his appointment as Chief Financial Officer of Select, Mr. Malatesta served as Senior Vice President of Finance of Select since November 2013. Mr. Malatesta is a certified public account and has served in various financial and accounting roles at Select since 1999.

Mr. Malatesta’s annual base salary was $509,858 in 2022 and is currently $535,343. Mr. Malatesta received a cash bonus of $265,123 for services performed in the 2022 fiscal year and he has received grants of 25,000 shares of restricted stock per year in each of 2022 and 2023, which were subject to four-year cliff vesting.

There is no arrangement or understanding between Mr. Malatesta and any other person pursuant to which Mr. Malatesta is to be selected as an officer of Select that would require disclosure under Item 401(b) of Regulation S-K. Additionally, there is no family relationship between Mr. Malatesta and any other person that would require disclosure under Item 401(d) of Regulation S-K.

Item 7.01

Regulation FD Disclosure.

On September 7, 2023, Select issued a press release, among other things, announcing the appointment of Mr. Saich and Mr. Mullin as Co-Presidents and Mr. Malatesta as Chief Financial Officer of Select. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

The information in this Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

	99.1	Press release, dated as of September 7, 2023, of Select Medical Holdings Corporation.

	104	Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the inline XBRL document.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		SELECT MEDICAL HOLDINGS CORPORATION

Dated: September 7, 2023		By:	/s/ Michael E. Tarvin
		Name:	Michael E. Tarvin
		Title:	Executive Vice President, General Counsel and Secretary

EX-99.1 2 tm2325650d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

FOR IMMEDIATE RELEASE

4714 Gettysburg Road

Mechanicsburg, PA 17055

 

NYSE Symbol: SEM

 

Select Medical Holdings Corporation Announces

 

Executive Management Appointments

 

MECHANICSBURG, PENNSYLVANIA — September 7, 2023 — Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced 12 executive management appointments, effective October 1, 2023. John Saich and Thomas Mullin have been promoted to co-presidents of the organization, and Michael Malatesta has been named executive vice president and chief financial officer.

 

A 26-year veteran of Select Medical, Saich most recently served as executive vice president and chief administrative officer overseeing its Outpatient Rehabilitation Division and Shared Services operations. During his tenure, Saich has guided the company through successful growth and transition serving in a variety of senior operational and human resources leadership roles.

 

Since joining Select Medical in 2008, Mullin has held operational leadership positions of increasing responsibility within the Critical Illness Recovery Hospital Division, including president. In 2018, his role expanded to the Inpatient Rehabilitation Hospital Division, serving as chief operating officer. That post was followed by his appointment to executive vice president of hospital operations, including oversight of both divisions.

 

Saich and Mullin will closely partner to further create best practices and enhance integration across the company’s network of more than 135 specialty hospitals and 1,900 outpatient physical therapy centers to continuously improve patient access to Select Medical’s care at all levels of post-acute illness, recovery and rehabilitation.

 

A 24-year veteran of the company, Malatesta has served as senior vice president of finance since 2013 after holding a variety of senior finance and accounting positions within the Outpatient Rehabilitation Division. In his new role as executive vice president and chief financial officer, he will be responsible for the financial planning and analysis across the entire Select Medical enterprise. Malatesta will report to Martin Jackson who has been elevated to senior executive vice president of strategic finance and operations.

 

“As Select Medical continues to execute its growth strategy and mission of providing exceptional care to the 99,000 patients we serve daily across our post-acute continuum, it is critical that we continue to drive high-performance momentum and create continuous trajectory for long-term success,” said Select Medical Co-Founder and Executive Chairman Robert A. Ortenzio. “These executive and C-Suite appointments represent a team that is highly adept to navigate our future.”

 

 

 

 

In addition to the four appointments announced above, each of the executives identified below has been promoted to a new position:

 

·     Michael Tarvin to senior executive vice president, general counsel and secretary

 

·     John Duggan to executive vice president and deputy general counsel

 

·     Tyler Hollenbach to executive vice president of strategy and growth

 

·     Mary Lacey to senior vice president and chief human resources officer

 

·     Shelly Eckenroth to senior vice president and chief communications, marketing and branding officer

 

·     Kerry Dishner to senior vice president of functional operations for specialty hospitals

 

·     Bridget Sherick to senior vice president of accounting for shared services

 

·     Robert Breighner to senior vice president of compliance and audit

 

“The foundation of the company’s success has always rested on our people,” said Select Medical Chief Executive Officer David S. Chernow. “Under this executive management team, we are confident Select Medical is poised to continue building a strong future for our employees, patients, partners and the communities we serve for the many years ahead.”

 

About Select Medical

 

Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities. As of June 30, 2023, Select Medical operated 108 critical illness recovery hospitals in 28 states, 32 rehabilitation hospitals in 12 states, 1,944 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 540 occupational health centers in 41 states. At June 30, 2023, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

 

*****

 

This press release may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time-to-time in Select’s filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine Select’s future results are beyond the ability of Select to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. Select undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor inquiries:

 

Joel T. Veit

Senior Vice President and Treasurer

717-972-1100

ir@selectmedical.com

 

Media inquiries:

 

Shelly Eckenroth

Senior Vice President and Chief Communications, Marketing and Branding Officer

717-920-4035

seckenroth@selectmedical.com

 

SOURCE: Select Medical Holdings Corporation

 

EX-101.SCH 3 sem-20230907.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 sem-20230907_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 sem-20230907_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2325650d1_ex99-1img001.jpg GRAPHIC begin 644 tm2325650d1_ex99-1img001.jpg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end GRAPHIC 7 tm2325650d1_ex99-1img002.jpg GRAPHIC begin 644 tm2325650d1_ex99-1img002.jpg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htm IDEA: XBRL DOCUMENT

Cover	Sep. 07, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Sep. 07, 2023
Entity File Number	001-34465
Entity Registrant Name	SELECT MEDICAL HOLDINGS CORPORATION
Entity Central Index Key	0001320414
Entity Tax Identification Number	20-1764048
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	4714 Gettysburg Road
Entity Address, Address Line Two	P.O. Box 2034
Entity Address, City or Town	Mechanicsburg
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	17055
City Area Code	717
Local Phone Number	972-1100
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SEM
Security Exchange Name	NYSE
Entity Emerging Growth Company	false

XML 9 tm2325650d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001320414 2023-09-07 2023-09-07 iso4217:USD shares iso4217:USD shares 0001320414 false 8-K 2023-09-07 SELECT MEDICAL HOLDINGS CORPORATION DE 001-34465 20-1764048 4714 Gettysburg Road P.O. Box 2034 Mechanicsburg PA 17055 717 972-1100 Common Stock, par value $0.001 per share SEM NYSE false false false false false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://selectmedical.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2325650d1_8k.htm sem-20230907.xsd sem-20230907_lab.xml sem-20230907_pre.xml tm2325650d1_ex99-1.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2325650d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "tm2325650d1_8k.htm" ] }, "labelLink": { "local": [ "sem-20230907_lab.xml" ] }, "presentationLink": { "local": [ "sem-20230907_pre.xml" ] }, "schema": { "local": [ "sem-20230907.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sem", "nsuri": "http://selectmedical.com/20230907", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2325650d1_8k.htm", "contextRef": "AsOf2023-09-07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://selectmedical.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2325650d1_8k.htm", "contextRef": "AsOf2023-09-07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://selectmedical.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001104659-23-098970-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-098970-xbrl.zip M4$L#!!0 ( -:%)U?AN?#-*P, .\+ 0 8:>,(NL1=Q0!A(U M1! RT& V$D]5=%0H50ARW2UTGX#[0CZVFU/=5ZU#5?6\T6A4X.(-CX0<;''R>].__7 M2_O@^-MPK(.K=W;5B?&.0FP.F:4#U?!2Y5*Q8MW,V@..>Y)EDF7/;O= MPPJFRF:7;L!3KC3F9 'OZREA'GSD)9L+4+H2>IQ :0;U80FG@!0&XLTS&P9_ M6,Z D7('&(=3 UA[@@'4;_N),LY MQ4S3AS[E-/:?SE,)N79Z(INP6<;,FK<,SBM%"OP[?AZO0PG*T..\6L:0\E/( M9JY)@41L+^HLODW,U)Z=9NZ8L[%J0Q_%XUBUC5-W%+47HI/:7B7TC0T"-ZOI M=Y-UP?15AK .-DQC7*+E@TK]9A)8DIQ*[K8P(B($J:EI[KDK(8F<:DN_GW.# MK!_E(._?)$R[\L#6#/9"JD1SXWSIALU^1:T M!(FE-E#LFYOQ7&MR2X=NN508*W\6Z2Y!S$Y@MR RWAY!K+G75_E7Z^!V$;?0 MMD[7?!\V.EW)\8!IE5GV#F'^:_(7,<0R.P6Q4$Y?2\]*6-%#U]2Q7%H?SI^8 M\;O:JPF(B+B6DUT:89Z2O>Q7C=E_P':%R/!)$>ROP;YN]^B"O/-5+5#S$C6S M_ U02P,$% @ UH4G5RZU(T7]"@ @(8 !0 !S96TM,C R,S Y,#=? M;&%B+GAM;,V=76_CN!6&[POT/W#=FQ88Q^,$+9#L9!<93[(P-IMD8\]LVT6Q MH"7&$4*3 24G]K\O*8FR1/%(2HJ2G(L9C_@>ZJ7XF*2^CC_]N-M0]$)$FG!V M/IH>?1PAPB(>)VQ]/OJZ&%\L9O/Y"*499C&FG)'S$>.C'W_X\Y^0_//IN_$8 M726$QF?H"X_&<_; OT$/.T$^$$8$S+KY'WS#=JBW\*J%$H!G?/%.2$5E0 M[/@,_?UH>AJA\7A O=\(B[GX>C^OZGW,LN?T;#)Y?7T]8OP%OW+QE!Y%?#.L MPD6&LVU:U?9Q]['\4X1_H@E[.E-_K7!*D#Q>+#W;I4-[,LVS_+%%*$T7"J-SV*,B#W0P58J+B)XRL<49BM:-3M:/I/]2._E)N MOL8K0D=(*24?8+M.&W6501/79N^(2'A\R=[GVHSV9%]^=T3V/S2@'N^\"4N> M8?HN\_5(Y[9OR/N.^"'._9&6XSQYWY&N1?Y?;&=MRV\^O/;C2M7&:_FI89'L M,CF!D5B;5%5TC,#Y'O*)H:R[JIU'C7JI&LVY:+==S8QYG2F)CM;\91*31-9] M?*(^C-6'O-GR/W_,N%P)7*S23. HTS7ES3@?6J7N%CI* MI:,-E0JUI")L_'4Q^B'7H-^UZC^?)H=:''2T7 )M-X1E2UFCI07-8E?=;#.E M>[E>%D0G6PR9?:PE2&D<=_"%W'&L=GY%\=IBWRAWU<566[J/&X5!=++-D=G+ ME08ID:]N_D+22"3/:CG?U8Z&S'FG6TRV^KZF"0N!MC&8A)K6T\!^3]:)FEJ4 M!75^2]3&CF$,T+L>^CMMFW.!51P$-$,<@K-%/0A549XXNF!LB^D]>>:B"Y^F MS#4U-I,F+'5-4(Q8C(%H%%I4B#T1\>M6GK$30?>]4+24KKD K)IH&+*@Z+![ M P&IY'X960K,TD0-8+V0M*7.3S< LZU3#T,7%"> .?B4I-+[)67Q2"A5]P,P MZQ]0;&+7M,"&35[:RJ"( >V!S.01J P)!YO+%[4ZE\ND@8VMZ7W"T[+=Q4\E M#A8AT^% BO(PI.(\D52[#='#4$OIFA[ JLF-(0N*&+LWD)5"CG*]?T@N63P( MD4KG!Q##IAV/4A0@'$UG?6A(M4\PKI(TPK3PNEY?9> 9>HA1K YILPM 7:330J:FH!(L!H# M:#AH\V=*O1 QDR.3P'3.8K+[F>S!=K5T;ID ;#:A,$0!46%W!F!1BE&N1E+N M!8P[D6RPV"^2J&>J: O=H@$9;;)AJ@*" [ &T%&JT6(^\SF3+/%N'DM0DX>D M>!Z\AQ)0[Q:6'MM-9@!Q0.AT.P0(DD&H&>43I#F+N'CFM<<=9GPK!\#]C,?P M"J4GRBU4@YK01*LS)"# AO@$,&N$?BB>24%35X!4#5Z(NXAC>:#2\I_K MA)$IV'ZKUBU='7:;3%F$ 9$$NP/X*94?] >D8M M"P6:XS^(?F9"@T)T%#<_(N:&3'>QUK9O+CK5CR5]O#V:#2 M"S)MJU9@#K+P<&EYZX-%!:CUC KQB4F^L+H5=X*_)"R"E\R0W LP@&DK-88V M/'3L!OOXJ1;$.L[K6%,LRGN_)%KF9Y1IFK0/,84F/$B:QGH'ET+M$XD[GF:8 M_CMY[CP1MXN]X&$U;(6DH0P/%9N]/F"*&"2#?)Q8E[BJ&QK65\F,O %ML M'5X!KA4& 8'-4?L5X.+J22%RWULC"ZN&VHUO?(&?R 0%OBJJAPP9?9Z+D.YSM/5>)5A(K4/ MW[4R9S.[::>:R'5!$+UKNFE-T[K<<6_^)I),[GG&-YLM*^_RV)X;!'2N>KG3 MINYQJRB(WN]R9I)0:E%3[!B+!:=)E&0)6_\B3SY%@FVMLHE< 0$;U#2T%4&@ M -HR.3@(D58ZAN!.$ 4AD1V1OP2H$@N)VX<'ZVS?)78%1;]A#0>L# *27GLF M+#)@'-4B4!&"\AB_V,S3=$O$F^"QA'A""#0/@-32AX@39+(7JB+0)UL+$FWE M_+B?'J^6249M)Y=MB;,Y"3!7S4A&>1!L *9,%O(RQ!_0]/BOJ[\A'>6X^V_X M4F"5/':QWZPX!;)/656N(.BPJ#FP2() ?9ETG##42E%A=9'=JJ&64MSC')7 M %AMZ:YO% ;1Z39'K2]_HZ\]#?F7N^A1FB+ "PEVF>NAWV;2'/[KFB 0Z##6 M.BDII4AK?;R0<)BRUOV+@+6W1<"Z9Q&P#G$1L!ZZ"%A[6P3HW18I0N2X=+NB MR1H#R0D[U:ZAZ+!L\F&1!H4*[ \<,ZH0=(AQG=$R3W&FTO.+3;[_*_G!TDI MYRRG99?-*JFE310$(UW.6FDMBZ1S-3%2:M=<;.,D(W%AYBIAF$4)IE5Z1-L5 M\?X09[0,-%^!TZ,/@Z%A)ELX%6$ZEV$5>$AUZ?I2>O$ QF^$TI\9?V4+@E/. M2%Q<2['=*>K6NWUBIL=V\Z$90!P$3D,< H_.J*#QDXI".JR\$N:%I&^<;EF& M1?XNN;"-3(#.+3F S28QAB@@4NS. $(J,2K4?E[0+K)'5(NLXG>'P 9"O M:W>:-M[:MFH#8J;3(/0.=YGSX[ V+J(\O6*9$?5[$<=3XH;*?>*8EL5V[IA* M$A >-E\=&60$TEHO+"PVF-+/VS1A)(4G(D/EE@6KQ28+#4E +-A\ 2SD4J2U M7EBXW!"QEM/;3X*_9H]E?E:P;8#:+1N=EIN,6*4!L=+E#V!&AZ B1J?4]0// M[I!0O,BR"+?4(G6,#6C68*:E"PD8R%R+%DHB=;WEAF=HR='7E*#LD:#+\F?H MZIG@BWI\_=)(%*D7(HI5.8NQL"'4)7;^JR.@X=9OC[2408#4:P_^'9(J ND0 MQ]3<2H9%_3PN-S'/R 9\VZ$_Q!5!0\UKCOKT0= TT*3)5![6/+G. Y&*])G- MJ)[<'E[B-42.5\86@\;"N*8(@A'0%K0LKO]6@)_<>=L53:(KRC%\E:6A<9PQ MKVW/2)9W$ 1$0-L5E"(O%Z)3+7&Q@$A&]U"YWJI:A> 5JI M9\3**M#OJA*4UV+[_?+ZIFOY26[6F^1?*YP2N>6_4$L#!!0 ( -:%)U=_ M]9@%60< -Y7 4 Y_+#DY<4+ M#Q"M"&2L$BXGEZTOP_;5L#<8M"*3 M,9DPH21'*]^RN(7@LNG<_=KQ Q$EI=D^/C;N>?3[?#> HI:W/IN,706I=RM525ZYZ=G76* M;]>F!Y:+D1;K-DX[:W !QI'[:Z.W:=6 @#A+(>$Q$RYJ'6?1Z2G;*ZV[ M1=FIAO%ERT!J6S@Y/3X[?N/J_W7')EO.;.N1*K7M.-VJZ+Y:EMT'XL+5?>K/T1*MYQ0;A0J#VY MZVY= #<0'TW4!W+9&\?Z/D7:6-"//?.=,9:+'$D#XP1L+^G1*V1R$1[T?-I.&. M#P;XH362^!^D-QX>C43(AU,0PN5R3*)Z>94]$OL;2NQ^G:\ _,VSN[[;2PN> M_581)/X_7PO^ [5$$;@'S55B+^D:P?[ &$G]C)*Z1R$I[QN98&EO3-'Y#SWL M/7E$J/O"_7 M>L>9X*CBM\8B)TE ZT0VS/Q&9CQ;NH?_G_-T]./!Z2[K0RLL8Y*DTR>*A.WZ M28/,W)Q&B.^^)98Q2:X9$D?"N6?U:"8&,H'%1UB&0!^88DF3Y)A!>22H[S5/ MF5X.>5P_:!S:8F&39)9A@22T']EBD%A5?,S+6<%ZZ-XB6/8D:25*+DD(!C)6 M>J:V'A?W5&[/QV5/)<$AO:8@-APD^>8+I),$Y2I)+"ZS^G/+)71#H:@T1\\1 MT04@(/.58#]Y&?83/':2/+16YBO!?OHR[*=X["2Y:*U,2NP]^_%./ZJY9P;: M:XQ%3I*+UDBD!%Y<:>[TO5;/O%P<54?]H 06/6&*&A9+VN'+BSRFMZ\ML;P) MT]5J<92<[Y7)F/B/S^KN)*OML0T*8?,)9Q=P\M?$N)]DRP?$ERU4HY M32-U$=; _-UWUP(+E"0!K1+3,,];Y>8^IDH&G\<>6F&YDF22/E%-#[QN-;'Q MGOI;7Z-7L)$,J_LR&L;X3?/,>M!3:9K+U3,:SZR8QQ2+ER3]"\IK&/50"1[S MC,O))WN'J#D3U9RK[+"029(]O["&"=]K<)$&>]M=K.-RVPWTW7CL&WE#]ECB M)+E>O5!:\@-C$R'2GAWQY2:8@E3)+@!:0U#'G'CVJ\>R98L"297:4< MHC'A9A%/F9R ?_5"M246,$FF%Q)'-O9.4&/OY(5C+TG&YQ-%Q+9<&V[/J+N1 MX!/FWTD6+(#>9T-)/""UZ?U[Q98?MYU;IX4???NA&KO'% N<9HMD2%[3J/.$ M9Y"4+O6Y9#*V*=5F7YLG.Z\OA0T S1Y*I&B2Q_O?0(B/4LWE$)A1$I+R5C_T MA-];!!L%PCG$&KDD(?BJ1&XIZ6(AJ/:< QY3+'+"N4.//)JUE^6BYLVUIWQO M1XBXKP06/.$D8E@LT?JT#)S/_!G>LXRM/ SQ]Y7 \B><4 R+)5L_KWOVPC-1 MX3GS/4,L;<*EL)722" /4R;$=6ZX!!,<6_8,L9 )U[Q62B.!?)."GMA![8-6 M\VRZVML9@NTI@(5.N+(U*)4&_N+'/O)R_UN0?(4U^NT$A-B](JE>NQ'';B%% M>267"=,>ZB%[+'?2C95^H0V3O\NFH+?OGPIG!C9O"RUZJ"^%C0))NHH537-M MW=K)'[RT[MAA>1,FIE7":/9,Y2/!X[Y0+'A?OF.&Y4N8A5;((L%[S>23SF=9 MO+S7*@9PTR=F<[8A$B)D!=B0$.:G+T)!\[A I:G;3*3BI^'4BC9W>5:\QM3Z M%WQH$"R'#0WE)DZ$<**[(/-CHQ89%=VX:>PC=%B.+8^)"^ M40B-H2),%YT#7;?V@'M1;?F-^^5>QFJ/_ ]02P,$% @ UH4G5TN"M2#^ M%P ;(H !( !T;3(S,C4V-3!D,5\X:RYH=&WM/?MWVKC2O^><_ _ZN-M[ MDK,!;!Y)2%+NH4!:F@OE\/'UFG7KF/P6%=\$DZ2SRZ AE9]-B#:>3I..:ZS.7:' M-L0&NXRV"AH?Q3FPX[>0R@VG>D.E]PQ6/LK*3V@=,H\2!)1F/WU^\S95M4R/F5ZZ,[&!XYK\]C;EL;&7 ME7J8Q7'9 .S1_Z73Y)@S0S\@;>8=DG,Z9 =DK(\/2:,F_KA2N0)RKQ;(O K)7 %6X7@Z:IWAQ=H5 RD#&N#?N@ERB!N.+9*G!JB,M% "N_@-)2X%U+GQ#7 MFQCL;:H'(GA 5,7V2($7>BYLH>:$X/ M7.$G85(BG-_!0-A*4+-TJ!69L:NG@E8/; &T\J%M,*G_P4QQV'(VU_*=<#+H M)I;X(*"2<'V!RM VA5V98.KTZ?0YU[&EQYE#!/8LT>]4&R?Q!9@?/)LNFSA? M,)L-++7T12S ^3M>C7JL/",AA#1K6Q@&J[=D4-@RCU8,@?!AP,8X;WV32\:" M1BUP<\BHZSNL'*C> ?0)@85-\2D0VA+X4H^73A$P071:>XZ9O5B8!W0;EG&1 MMSA6Z #U+"?2O#H/YG%,@AJ9M,9,:\C-NZ:]FR_S\R8!#MMC7%A@:*"5$1V4 M%B$T>T=9& ^?^+\C.S25*%,0,Z..'! EDRMR\Y"(A]3@??. :-#"G$,RI$Z? MFVG/LJ&?[4T?="W/LX;B6:I\U"W_]S_JKG)XE.U"J&&+Z:+^HN4;+'U!^\*M M14WV/< ?DA'7O0$Z!.5-*C:Z:SE I!S]SJ#:-QN$8;Y]S[I Q=B!%ST_ZY_-& MIUXC[4ZE4V^_&!\ D7:]^KG5Z#3J;5(YKY'ZU^J'ROG[.JDVS\X:[7:C>1[% M[J78=5EI?VB3Y_,A]A'6<3N=S&^K\KSJCS!X@BEB49STZ+; ?%M MR"4T+*"ADFF^ QF;M[GA,-MR/"G*0JI?5ODO/K?:GROG'=)I$G"L'?">1,V3 M9HNHQ2U]FS2/7]+5=S[42<3=3UU]I=H!S(A:RA=^$Z/P_+S!])58/=(2 D6V M\/OF!CQ@%'(3YGJ$W0!((@6.Z=L'R"J"0>R@ ?0A]!SJ=3 !I9B8YA1@RJ7*;V3"JRQRRMT,0 M\JNO6/ 5KT[J-W=2B=,7GMQ1+49WLI+:8GWNHN?RL)JOW ;GPY4NGX*CF=SXZQ>:U0KI^1#\[0&F5,;$KK61;-5Z8B,;E[+E_C/ ME[#$6_4QU3Q1BI<&.:1OPBZ_F MZ9Z+X]&NP0""8=A4ET<'E)3X#AJGA=]71B_@EV89!K5=8$SXUQR/$0,G!'_# M' ^W'D.Z)-YAE?K(T\.. 8A\[DV<^8)H\6#$>'_@(0A#3V+6HIVLQ^QDP]0L M!X(IL:'>]B >J)@E2P-_[L7^9^_EMIS:+%_#RX_:6F\X7";O'?PN0.'3>"#3Y-R-UM'*?\IC$P3Y5! M4WT0QY=,FBKGE+2ZMUM0"ONW\C_K.6L:F/F.8%(3.)O(1H@1A$X2RR%-;P#9 MRT??X:[.-:0 @X:CKB-V>&-Z++H[?6KR7^)[$#;$Q>A!:$5WC)*$Z&$T5ZWA MD+MX%(V@HA"Y5(E4W-^+)**T)GE/,^M6(]/*M#.D/K0-:P*++1,*NRE+^+*L_2 6OZ+K#7#?X..4F4Y,M M2GVDU$Z<[^IQT7B014F8,%4N[*D%\IYYWL3M^DX?R*7Z$KNRLU \K]Y!4"Z9 MH,GDW5G_IW71*N0?F:!)7%?YL.AUK M9"9SJZ%]Z'B?BP5VL^Z^PY+I4N4SI@W Z&IBZ>^]ZI4D*H39;SH7$+IQ4UL2 M)3J?C;TOGVY.BB?]QR!E;DY8^\H2(A9H*"31<&%!^&E\Y_;R.'?_@@_SK/YI M4,@]!@6Q&5-E=4\I+H^JGD=FMP+4T%E?.,!7;E.#U,=,\SU^PTBS!Y:=N=MD M"]#>W$#$'YSEWP.SY[+96\ML'.I-Q6%TN6SPSVV3?IQPSM>5C>@NK=$ M%K87Y+D88'EJ@>^^&%CFK5E![?KZ=+>B6&?5XIJ8SL^3*I?VL%NSK;Y%G, MV[,L0!LLI<,]#F <(8W, 9IMWW%]$$L(J &63(?4W%9W&^TL9$JDHGD'SRM_ ML^I7M-HU7PU;&9%(B>N64M@=U2\(ZA,R4PDMH0@9U@#VW]R6WT=(B:1UJ7(' MWU8@8D=1&Q#-H*X;3:67H+&D'AHT.K+DL*QYZ4'!L#!26(\2A^+"D?9DV+6, M+7?[I>E8Y9VO4-LZI ;:OB, M_*5D%$4E-AZ9']Q6=+U;!M=E_L/9JP3L#51':DXR;SN__.;%I];7G\UU$_'8 M)+@C>/:/Y%EI3B3K@88NWU;5=^N7CMK^4>WV'K0_@+9@<6L@"0\P(N"AOEG. MM11<$C8N2Q&WSK^UZ]M)!F5:IWJP7W[B$.2'[WJ\-P&-'3"@&,,*:MN.93L< MB[)=:TRZS+!&&(QA(\9HFQO[Z1/2XP;Z#>Y"<.PQ4X>(!0(5EP]]PZ,FLWS7 MF!"7>MSM3<308(#5A9EI6-S%!F<:@1,?X#B$FI.PK0?.WQKA.-SBX5@P=4NM[*7H*8@7^A1 M?#.H$+O))N.$\U:I>Z$6JJO5O:)'K[J693!JBO?9H@8C$0TI!?N']S#)M_,X M50[@ Y[1"6)) &Z$DT*N&&@)JDZ1ZW"+ D QTW Z<@;!*CU,[ M?]6)E]2)<#N@#6Y9@V4W^V=@I<%4+PD_S&_:36WR+F?G!H^N$(LX/*(VS(## M\DKHBZJ@%FA:S46T(?37H2X(52@H&=GQ51O^4&VXLD3= CMN8 MX5&7Z*S'37G\5P:W2C%,_.8B6WBJEO)YLH6D[AV* #?L#-/ @MAX>!BW$>2R MY;KI7 *LV-I)H(4I4%S"V;@(V,PS)Y-/-$M]R4HL-R=WW&^REATZCFVDASB] M%RA5)4;))NC7<>MR7/SZ]>/%:B<3[V.";D'FOM8G^/@3!*71NT5Q<3/KI2:2UBJ75&+M^,KN_!F0W@'R\+T#J/7Z2X#;00<;8%S=,K=A!D1 MC56GC"[ITZ[F$R45L0WL^[UX<^>68T)*<$NZH(JV;KGAL2$I9I1[X@-U!IWP$1:CHN6M@JX48C.Y!$NQSTD=8--3V9/NQ[BX1&+FYX( MJ:%E<1PZ4V:Z>(/0A%0L879(0SR3$V>5@2) MGI*D2I(RI$8AE"!5"&Y,:P3Z;A@0S1## BD&168.#,1I0HB(4L $*B4\">P. MZ?J>!(;Q*S=])O;00G#5 6>]A8.4SN-E(R\I/Q62VTWCR^WDAD&.1B%Q9(XVC)#[O@A4 Y'Q!H[E]P?$]34 [/9\8W,C MB,%QXDBXC)P0N[" $KFA#F>>V#IUF8AO(V 4OHVB!,QE22 )_I MV=*9^&9( ]%5]W>$".':0+8$24:PRXZ3-,Q 2LF83K(\1"'B,%%#)8J'O!HBD!SJA&1$[12\_ @"O:%H&A M] #1/T3^XOH]M2O@P'P*FHPW1Q.7&A3DP16B^I%"BS.)^H:<$,LN8R;Y:U=1 M=A1%D1K,1 .:0HXVL(])MI#,O:+H%-Q:"P_@PW.X2+Q=<9P%3UT)@PMBBL?D MQ)4H8BZ$+!V2/"TW8F"Q7+_[0U@CE#>',6FL-8/W>F"R792>/VR]I$%X^((5 M=]77!7O"!>L,D%PP2A""T5DJ 0G+YH8HTXL:$-J:+O-&N"1S+A=B@ 6<=[$:%2D<24;?#0A=O@5" ^L1UKVHJ(-;8>31F_EYL+@CRP??X^!E MYT"4SEW-L/ FUF##021T!47=ZF[+:>0U&KXAC7T[?9+!$_-<^BUCLH/.(>3. MYH8L6@%XV5\XM 3RM,@:^\M^6QE'#M9:G M7RC/9R _E!GD&-(LL),>&!L*25A!9%HB(DKF9"3D7YZ!;6[(%.R,.F#"<(Z/ M5+M&25R6AMTYFTS*$E.]VW(R>6F-#*UO"X#:F&RP/M<"')A0I%DT]!N+_@J2 M<^$@'X W\^$A=3; ^Y8=X-:H4[?$S'5$I8&S%G M#WP2X"9BH-L#L=S*@1BY+0[;W(@$8CW(M%_CL,608[;:JP9>LY$BTB*W!5I3 M%_;DD1:Y5Z 5L4./&5K-H_G["M?]=L-RK[MAK[MA=^Z&W6\O;"^CJ*OLA454 MZ;A&:E/MR_SCMZ36CO\YGL=#;VR+6Q[ Q#%P^!#;#RTLYPD#AK7/OCO=I4&; MGY0GQ#-.M($+*>?(\\%@0Q1O3]\FBA& AKOG.R9W!^%FPH!W MN274@=?KS>$0$54 ^ MJM/F!NK3]%%5!G3A1./=@*['&#Z<%.H(C](#RP+9>YHB 6G.@)LKC]>Q[Z$ZDI''%78G5#M#E!!3R10*C(A43);&C ^%! M\-+XFF@8FKQ0;=Q_E-^1UWJ$@6E(PM/6RGX; MR1&_=K7&Y8DKXS1GS/$:@44!7)W2^;<- KB4R)_B\X:Y?*ZX6U1T]8J-2Z6T MFAEX0 ^:]*,L?? U@FM,?1&/1W0:Y(#"*23&-)&RT6V'4S)3@H(7NI]Z91>) MC]Q?^O@0GPS3/X=;JE)X?%95<>];I+ND@;0/&Q/140]^&B(SMQR_N]>X1U$@_UH4>):B MP)-=]]5NO#^O=#ZWZG_"WEE.;H%$RI3R)@M1M)N>2HP'[)L;R8G(W!T86*76 M?0C.->J[8K\-CP#)#"NH=P)JT("YF8=G#B"[Z&$ CX!DW55VP/S*-V&, $=] M;V Y_!?3_WEQ_/WOQU_?]RR]MUG0Q'O3ZS8M<$W163/$KG9XI* D$LE-XD!K/KO6.W<*5X2ORZE?B-\Z0( M=\F[L"M3D7OS6 %C + ( -]-#FZ]GNK6W\)=;1'F+\.3BY!ULT$9,3BP4,^0 M#L6SD2^M%0\P(2M#P;NNEBS$0VS/OYJGXMZ[)V#JLF,F.]/[K_#'3%PFCR5 MK.$PCSJ3/R_\+QR2IBUV5@^(N ;VM\D&_CFA>?0WKB (M_2)N*1@X V-/KW,GU9OOY[Q@?VM]^]EP]H[UC_I@.)ET__Z@&=WWQDW]^^7Q]^].X7OC MJ\W;G[Q.0SL?&T,V&N_]M+UZK['_;7+FN;5^^[CGO#L[/=^_/-&^Y]32W]F] MBE$YJ?5;IEJDUXU/0[_TOJ ;%;,QX>=?(,^H??Q>X^]W/W^O?_VE&.S7-^-R M6%+>Z3\OW??G/W,GM:_9IM4NW=@?#=_^>IG_4M&M[V[EIW73S%Z?NU\^C;O- MH?]AO_7UG3J\Y#]_?.WP]F7GM#>\S)__,H<_OWU1^8=3CPVR!>7O\V;QH]9_ M^U:RY/\!4$L#!!0 ( -:%)U? <= : @T )$\ 6 =&TR,S(U-C4P M9#%?97@Y.2TQ+FAT;>U;:U/;.AK^GIG\!RT[VSF[DX0D0%LNA]D :4N72X>D MG>FG'<568A7;\I%DTIQ?O\\KV8D)"6W/T&YARI> (TOOY7GOXN#-\/SLL%X[ M>-/OG>"3T<_!\'1XUC\\V/2?^':S^/K@Z/+D(QL,/Y[U?]\8J]3NL4X[LVPH M$V'8A9BR*Y7PM.$?--A :#G>P(MX]=VWOK?/$JXG,MUCM+2]SZSX;)L\EA,\ M^I0;*\>S?1:H6.D]=B7"#5#\[F'.VCA\]O>7W:W=_;L[5HG0'^'KSK'9=_ M_\53FU9E>Z2DXL^1LE8E[LE4AC:BO=K_ ,O#J_*(&Z&M#'A<2A,[K-0QX>=@ M>%*^5FRWXW8[/7_-!E?'4$O2W>KN/-]IAYW_BL^[N\V.3";M=J?U*9MLL-[9 M\/<-PL?PY+"RU0I=?M/NW5N[S^4]=*:R.;RB TGH#Z71N^#X@O#_TBOK<5/% MR3*.OIFW"BSVV4CI4.@FC#GFF1%[K/QMPSFE^U&S43BNNR!YOH6],QZ&,ITT MG8;W6+?U?">SB\>Q&+NG7?>4Z&\:^:?P3#@;?75YQ4[/S_LGI[UAGUWUS_J] M0=\;Z_!D[=E;+[[^;'HZY^)A':4[V;&Q_:*SS5X+:V=FE.L)=N+APN5\UZ// M11#Q5 ;NX 9[UV.=%^V=G1]T^AS0/^2TBX^#/AO,DI&*]]B@?UX>ZYT/>06' MZ+EG^)[!ZD%8"T1JA7:\#40L LO.14@FR-ZHF&!LV+'2F=+<2I6R7IJJ/ V$ M^<[A[+LQV?\L@MS*&\'.>#X[>7[V&8?8O+@8?SS[@40\H?9:$W$3[."6S(AD)79#ZHL&Z M[>Y6Y?LOP^*W9W'X1Z[V;Z]M/-/N*2N^G8KE)[DIG]1K2I=/5:Z+I_]DOY'% M.5/[)Z)!R&>,%Q ,6:?+Q%R=R4*=O*+.!A/C,6BB)9>!50L^.Y[/%GNKHI0- MN PB[!W6:\,(6C#L/(]CF;*(X\V1$"G+M$J4Q;E6(8(U,RV,)($;IL;,1H(I M/8$?_-.)I$%[L7-LRD4,K,7<"F,YMC-^MY0GV&I!_XT,!)OOZ2D)(BG&;"Q3 MG@82LE?C,5;IUA/!9X]UGS=G@FMV(V"?/"5!>@C5:R6&"LTDREBF!5ER/&-& MZ!M(#[*\3X#,RX^'B4REL815K"N$R!22#2,$L,PD='B9VPP+Z-4K$?&1C*5U MFJS73N2-- 1SVG,0<8VCP3L="-UGPAN!:;&37--VD31@.,VU**DGK4]R$!8Z MH 0JR7@ZP^]:Y9.(F3S 5F:!*1&1L>#(P$PD,Z95+,Q30=! PA&P3[!VDOMM M[^.$U6VW7S86IFQ8).+PEK@JHLF4%[T+^28X:ETF)@AM[41=B-% M'FOI\E5V&L MU6L9US:%KX$P5W+_EP;6AR#^-U")CPWXW MO,C_"GG>YQQ=PB$F,K@E]4JZ\$3 723M/7,G_A8N1)A%'!$NURJ2G$)"WO(3 M:5R.16X"OD8Z#(O/ :H3'ZB=2RE"XNYNHPU75L 3J!7>9%C()=Q5 08D/[=< M3D%/GB!(60;0!&7XMA01IZ)T>NZ<4)->(\2O)G0&'"9.B8FBR)@G'L[>F2]\ M)25MGR $!7]&T(U5.FD">$F9XRWJ'<-EN S28]5\!:-$0N*V7Q2KQQ&71 !T MAPH&%6N+76KDF']*U2K+IF$DC*A DG8X;@YR:46!CVIA1*@'7/$K@@,TRQ,O M!8B%>"8IAI ]22+E-W)"?)) Q[E%8MLJV/B),5QIC_ZMV62O)#*_/?8.12+5 MM'_D MK$MJS9+)M&)Z'&Q5+&EDL M]64=9;?#J\F)8/:\YY@F<[%[1!@5UB0Q#94$>+2V) MO>^C:(N@$N%4KGQ%0&VPB4 B36$ &D-R[;R;$7# ENO9+UFO_:#N5KUVDD\F M/+VWGB.!PN/G2!B79/U+NFL_AK-8Z'KM#6IHD8[(>WRA9+Z5\_@\Z)=XUSL* MV':]=L8#,:LXB;5UQ7+;JZ@N?@EX[<<@$C$U*OK!M4@UM6B^0LPH6I,\1<): M='S T;6P94DV0GT;5AI.OZ2_]N,_0A.^3Z2)BB[1^G(?>4I1""U*2%=BK&CW M_!+YVH\C+<.)0,T#Y&N)=/T^H2]:)%[2OO5OBM;_+RFO_?!5:KUVI 5JR2]A MFYI@L5PTIG(D[D]$N(O2G.J/-/3],S6NUU:U=(L>@2LO>#SE,ZK2#947]!)U M,X3*XL44=64+P;GH1>?@LAAWG:"(Q^(6%@B=JNF\;?">V@U$CS2KQZG4&VA0 M=X0:,(%*QUYQ2^?B;916IAR/%GV442[+;B0R'T6&Y/H'SIZ((P'5JYD@69?= MG,:\;^[[XH6D*.1@0:794_8&$YJE47L5ZR/!PT?0G%AS%^[@Z/#@_6%OI/)E M^1YLOC]\0E<3[H)'I6)N%S&VI?F(CW1*N^'!O%E73 X6@X-YW&LLS0^JWU3& M'DN+@EC2[24_L5=!D&?%;+!> YIBY$3E6*1HC+\'$&D$;*F)S$;<> --<[I% MX8(U#VA[@+7%>H[XMWE:-N&VVO[B06/9@CRW=*^A_?(.M_7:77:)GNY+&!;1 MT6!;W;7LT\I.=[ZRT]C=WOZR1.BMK=WBK=(47;IB$3J=ZSY6,;B6W MO9[M] M2X#LKORV.\5^D(S]*K%$O-HU=WL\+_;P8RU2R2J::#KAVK9^DK;"J AW_(;+ MF-.H@5L&XYM.IRWC5B5^40N^AZSO\?3KR^M._Z*?']Q/[?X_^JGIR&0_N)VZ M^LCOV4V=G_@H,'B_^Q]2LD$Y('GQ6,"#8J^92QNX3.LUZ&G*==B,E;JF[,&9 MNQ];S-UMD&M-OJN2J8C/J(5L>1OG(D^$IID,W#$%D>K5! O72(/&N!SH^1J6 M* B+2:B[@>77A0)DQ5@XUBIA%C( ;)KT2>[(^Y1Y$C>&'Z7[<31)=;YI@)Q* M^]3%#W7HNBRP<8R!HO="0 M]$9TO0-G.]862)N+YT:**>4NI!L^OP@8TK",:%;C5BD7-]6S_!H\I8JI44PC MM6(\H<4-,F>25YZY=TE7]]&EM,?LM5^JW,V2I1?JM=N<"+>(*HM">D0M32SD M(DHV2GV+&W^Q4?N]IS0V?VR^AZ9 -T@CP81,_\BE!IX>W51FX_"M$C$;MM@' M\:!5\=%XT=U]TFYU.N_V0&WR*IJ24/VJH^FXRFS>3?PA*DG?5[M25,CJFA*7SYX4]I!N]MN;K>W M=AX6VD:4@GPJ$!]8_A7Y?U!+ 0(4 Q0 ( -:%)U?AN?#-*P, .\+ 0 M " 0 !S96TM,C R,S Y,#'-D4$L! A0#% @ UH4G M5RZU(T7]"@ @(8 !0 ( !60, '-E;2TR,#(S,#DP-U]L M86(N>&UL4$L! A0#% @ UH4G5W_UF 59!P WE< !0 M ( !B X '-E;2TR,#(S,#DP-U]P&UL4$L! A0#% @ UH4G5TN" MM2#^%P ;(H !( ( !$Q8 '1M,C,R-38U,&0Q7SAK+FAT M;5!+ 0(4 Q0 ( -:%)U? <= : @T )$\ 6 " 4$N M !T;3(S,C4V-3!D,5]E>#DY+3$N:'1M4$L%!@ % 4 1@$ '<[ ! $! end